Share

Cancer Prevention Press Releases

March 27, 2025

Significant HHS Workforce Reduction and Restructuring Threaten the Nation’s Fight Against Cancer

Today, the U.S. Department of Health and Human Services (HHS) announced it will be cutting more than 10,000 jobs as part of a major restructuring that will impact operations at the U.S. Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), the Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS), among other critical agencies.

March 27, 2025

Significant HHS Workforce Reduction and Restructuring Threaten the Nation’s Fight Against Cancer

Today, the U.S. Department of Health and Human Services (HHS) announced it will be cutting more than 10,000 jobs as part of a major restructuring that will impact operations at the U.S. Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), the Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS), among other critical agencies.

February 7, 2025

Arizona Cancer Advocates Rally Lawmakers to Support Access to Care, Tobacco Control at ‘Cancer Action Day’

Volunteer advocates from across Arizona, including cancer survivors, patients and caregivers, rallied at the state Capitol on Thursday for ‘Cancer Action Day,’ an event hosted annually by the the American Cancer Society Cancer Action Network (ACS CAN). Advocates met with lawmakers and urged them to support policies that increase access to quality health care and prevent tobacco use. 

January 29, 2025

Senate Introduces Bipartisan Legislation Aimed at Removing Cost Barriers to Prostate Cancer Screening

Bipartisan legislation that would remove financial barriers to prostate cancer screening was introduced today in the U.S. Senate. Sponsored by Senators John Boozman (R-AR) and Cory Booker (D-NJ), the Prostate-Specific Antigen Screening for High-risk Insured Men (PSA Screening for HIM) Act would waive cost-sharing requirements such as deductibles, copayments and coinsurance, for prostate cancer screening tests for men with the highest risk of prostate cancer, including Black men and those with a family history of the disease.